Screener
InMed Pharmaceuticals INM Q2 2025 Annual earnings
Reported September 23, 2025 · Before market open
Revenue$1.8M
EPS-$3.80
Next report
Sep 23, 2026 (In 5 days)Revenue estimate$2.1B
EPS estimate-$94.44
Versus estimates
Diluted EPS
FAQ
- When did InMed Pharmaceuticals report Q2 2025 earnings?
- InMed Pharmaceuticals (INM) reported Q2 2025 earnings on September 23, 2025 before market open.
- What were InMed Pharmaceuticals's Q2 2025 revenue and EPS?
- InMed Pharmaceuticals reported revenue of $1.8M and eps of $-3.80 for Q2 2025.
- How did InMed Pharmaceuticals's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 89.4% from $938.5K a year earlier and eps grew 0.0% from $-3.80.
- Where can I find InMed Pharmaceuticals's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001213900-25-090715) and the 10-K periodic report (0001213900-25-090210) directly on SEC EDGAR. The filing index links above go to sec.gov.
